Wal-Mart Stores chairman Rob Walton, 69, announced the appointment of Greg Penner, 44, as vice chairman at the company's shareholders' meeting Friday morning, a move that positions Penner, Walton 's son-in-law, as his successor.
Walmart chairman Rob Walton encouraged employees to “go for it,” and president and CEO Doug McMillon said the company would accelerate the pace of change during the company’s annual shareholders’ meeting June 6 in Fayetteville, Ark.
A soft cough-cold season has given way to a robust allergy season, Bill Simon, Walmart U.S. president and EVP, told analysts Thursday, which was one contributing factor to improving overall health and wellness by more than 150 basis points.
Walmart has gathered CEOs from more than a dozen global companies to sign new commitments that accelerate innovation in sustainable agriculture and recycling. The pledges kicked off Walmart’s inaugural Sustainable Product Expo, a three-day collaboration to expand the availability of products that sustain people and the environment.
U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.
Teva Pharmaceutical announced that its U.S. subsidiary has entered into a settlement with Pfizer related to Teva's generic version of Celebrex (celecoxib) 50-, 100-, 200- and 400-mg capsules in the United States.
Good things happen in small boxes. That's what Walmart is counting on with the introduction of its latest store concept — Walmart To Go. First the supercenter, then Neighborhood Market, then WalmartExpress and now Walmart to Go. The boxes just keep getting smaller.
But what if Walmart is on to something? What if tomorrow's definition of convenience is ubiquity? Then it makes a lot of sense to start filling in the gaps between the supercenters with smaller formats.
Pfizer has sued Torrent Pharmaceuticals in an effort to protect its erectile-dysfunction drug Viagra (sildenafil citrate) from generic competition, according to a Bloomberg News report published Tuesday.
It's finally happening. Pfizer has placed the ball at the line of scrimmage. And based on the X's and O's to come out of its Lipitor OTC actual-use study, Pfizer will be making its run with its eye on the ultimate prize — a successful Rx-to-OTC switch of a statin. Only this time, the Food and Drug Administration may not be as quick to sack Pfizer's switch attempt. With the advances and pervasion of health technology in the self-care space by way of smartphones and tablets; with the evolution of the pharmacist as a healthcare professional able to practice at the top of their license; and with the adoption of diagnostic tests like a cholesterol panel that can be physically administered in the pharmacy, consumers may finally get it right when self-selecting a statin. Because it's the consumer actual-use studies that have scuttled just about every statin switch attempt in the past. In the last switch of Mevacor, FDA advisory panelists determined the statin was safe enough for the self-care space. And it was effective. It's just that the consumers who would be right for an OTC statin didn't appropriately self-select. And if they can't appropriately self-select, what's the point, really?
Pfizer is recruiting for a 1,200-patient actual use study to measure whether or not patients can appropriately self-select treating high cholesterol with the statin Lipitor, the Wall Street Journal reported on Sunday.
Fresh and pharmacy is the key to smaller-box retailing, Walmart reported Thursday as it announced plans to increase its capital investment in smaller formats from 120 to 150 new stores for the fiscal year to between 270 and 300.
The Walmart Foundation, Goodwill Industries International, National Disability Institute and United Way on Monday launched the 2014 MyFreeTaxes program, an initiative offering free online federal and state tax preparation in all 50 states.